Wednesday, July 8, 2026

pharma · Hypertension · Uncontrolled and Resistant Hypertension · MLYS

Mineralys Therapeutics

Mineralys Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Radnor, USA HQ
2020 Founded
106 Employees
Public company Type
MLYS · NYSE Ticker
Company details
Status
Public
HQ
Radnor, USA
Founded
2020
Employees
106
Programs
7
Drugs
6
Patents
0
Intelligence · Clinical Trials

Mineralys Therapeutics clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to Mineralys Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Mineralys Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Mineralys Therapeutics.

  1. MLS-101-301 — Phase 3

    Clinical update
  2. MLS-101-901 — Phase 3

    Clinical update
  3. MLS-101-206 — Phase 2

    Clinical update
  4. MLS-101 (Part I) — Phase 2

    Clinical update
  5. Placebo — Phase 3

    Clinical update
  6. lorundrostat — Phase 3

    Clinical update
  7. Lorundrostat — Phase 2

    Clinical update

Trial registry

8 studies